Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -0.35 is 44% above its 4-year average of -0.62, near the high end of its 4-year range (-1.48–-0.16).
38.60% above its 12-month average of -0.57.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.13.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 12 comparable quarters.
EARNINGS PER SHARE (EPS)
-0.35
EARNINGS PER SHARE (EPS) AVG TTM
-0.57
EARNINGS PER SHARE (EPS) AVG 3Y
-0.69
EARNINGS PER SHARE (EPS) AVG 5Y
N/A
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+38.60%
CURRENT VS 3Y AVG
+49.64%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Spectral AI, Inc.
Market Cap
$53.62M
Earnings Per Share (EPS)
-0.35
TTM Avg
-0.57
3Y Avg
-0.69
5Y Avg
N/A
Market Cap
$53.55M
Earnings Per Share (EPS)
N/A
TTM Avg
-0.08
3Y Avg
0.02
5Y Avg
0.04
Market Cap
$53.37M
Earnings Per Share (EPS)
-0.39
TTM Avg
-0.75
3Y Avg
-0.80
5Y Avg
-0.90
Market Cap
$53.91M
Earnings Per Share (EPS)
-0.27
TTM Avg
-0.75
3Y Avg
-1.03
5Y Avg
-0.90
Market Cap
$53.02M
Earnings Per Share (EPS)
-1.00
TTM Avg
-1.43
3Y Avg
-2.38
5Y Avg
-2.90
Market Cap
$53.01M
Earnings Per Share (EPS)
-5.21
TTM Avg
-25.08
3Y Avg
-23.14
5Y Avg
-19.79
Market Cap
$51.51M
Earnings Per Share (EPS)
-1.20
TTM Avg
-0.91
3Y Avg
-0.56
5Y Avg
-0.48
Market Cap
$51.46M
Earnings Per Share (EPS)
-1.49
TTM Avg
-1.25
3Y Avg
-158.58
5Y Avg
-880.75
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Spectral AI, Inc. (MDAI) | $53.62M | -0.35 | -0.57 | -0.69 | N/A |
| Zhengye Biotechnology Holding Limited (ZYBT)vs › | $53.55M | N/A | -0.08 | 0.02 | 0.04 |
| Aldeyra The (ALDX)vs › | $53.37M | -0.39 | -0.75 | -0.80 | -0.90 |
| Rani Therapeutics Holdings, Inc. (RANI)vs › | $53.91M | -0.27 | -0.75 | -1.03 | -0.90 |
| NOMAD Power Solutions, Inc. (NMAD)vs › | $53.02M | -1.00 | -1.43 | -2.38 | -2.90 |
| ImageneBio Inc (IMA)vs › | $53.01M | -5.21 | -25.08 | -23.14 | -19.79 |
| biote Corp. (BTMD)vs › | $51.61M | 0.12 | 0.48 | 0.24 | 1.52 |
| eXoZymes, Inc. (EXOZ)vs › | $51.51M | -1.20 | -0.91 | -0.56 | -0.48 |
| Tenax Therapeutics, Inc. (TENX)vs › | $51.46M | -1.49 | -1.25 | -158.58 | -880.75 |
| Eloxx Pharmaceuticals, Inc. (ELOX)vs › | $50.99M | N/A | -7.29 | -67.66 | -178.24 |
Trailing EPS (TTM)
$-0.35
Forward EPS (Est.)
$-0.47
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -0.29 |
| 2024-12-31 | -0.85 |
| 2023-12-31 | -1.48 |
| 2022-12-31 | -0.16 |
| 2021-12-31 | -0.33 |
